Literature DB >> 3348501

Natural killer cell activity in specific and non-specific bronchial challenge.

E Vesterinen1, T Timonen.   

Abstract

In specific bronchial challenge with birth, mugwort, or timothy pollen, five asthmatics showed a significant increase in peripheral blood natural killer (NK) activity in conjunction with bronchoconstriction. In non-specific bronchial challenge with histamine, four patients showed a significant initial decrease of NK activity followed by a later augmentation of reactivity. The later boost of NK activity was detectable also a trend in specific bronchial challenge. No significant changes of NK activity were observed during control days when no bronchial challenges were performed. The results indicate that pulmonary hypersensitivity reactions are associated with augmentation of NK activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348501

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  4 in total

1.  Sinonasal T-cell expression of cytotoxic mediators granzyme B and perforin is reduced in patients with chronic rhinosinusitis.

Authors:  Sarah E Smith; Rodney J Schlosser; James R Yawn; Jose L Mattos; Zachary M Soler; Jennifer K Mulligan
Journal:  Am J Rhinol Allergy       Date:  2017-11-01       Impact factor: 2.467

2.  Pro-inflammatory role of natural killer cells in the development of allergic airway disease.

Authors:  C B Mathias; L A Guernsey; D Zammit; C Brammer; C A Wu; R S Thrall; H L Aguila
Journal:  Clin Exp Allergy       Date:  2014-04       Impact factor: 5.018

Review 3.  Natural killer cells in the development of asthma.

Authors:  Clinton B Mathias
Journal:  Curr Allergy Asthma Rep       Date:  2015-02       Impact factor: 4.806

4.  Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice.

Authors:  M Korsgren; C G Persson; F Sundler; T Bjerke; T Hansson; B J Chambers; S Hong; L Van Kaer; H G Ljunggren; O Korsgren
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.